Additionally, prospective studies showed that high IL-6 levels independently predicted stroke in patients with AF (Lip et al., 2007; Roldan et al., 2012), and the addition of IL-6 resulted in improved prediction performance of the CHA2DS2-VASc clinical risk stratification schemes (Roldan et al., 2012). This evidence concerns the gene IL6 and Stroke.